GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,590
+220 (2.12%)
Sep 4, 2026, 9:30 AM KST

GemVax&KAEL Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
85,10481,53162,69272,20975,80460,371
Other Revenue
-0--0---0
85,10481,53162,69272,20975,80460,371
Revenue Growth
24.42%30.05%-13.18%-4.74%25.56%-8.06%
Cost of Revenue
49,04546,71543,20946,27054,08241,704
Gross Profit
36,05934,81619,48225,93821,72218,667
Selling, General & Admin
15,88814,34820,78116,36012,58713,462
Research & Development
9,59814,63135,06415,67011,6347,241
Amortization of Goodwill & Intangibles
268.25303.91328.44300.61179150.41
Other Operating Expenses
775.11640.21354.7375.96291.92308.43
Operating Expenses
27,35531,02357,81933,80725,65221,117
Operating Income
8,7043,793-38,337-7,868-3,929-2,450
Interest Expense
-6,428-6,647-3,161-462.86-445.31-404.96
Interest & Investment Income
392.98212.8381.18294.97170.17272.83
Earnings From Equity Investments
-4,970-6,612-2,968-10,855-7,00411,719
Currency Exchange Gain (Loss)
755.9997.86-64.4480.3129.09325.36
Other Non Operating Income (Expenses)
749.56-1,165-24,132-48.49462.77519.5
EBT Excluding Unusual Items
-796.2-10,320-68,281-18,860-10,7179,981
Gain (Loss) on Sale of Investments
-11,368203.5-18,022-2,531-8,5382,166
Gain (Loss) on Sale of Assets
35.0411.55119.06-253.09-83.14-6.64
Asset Writedown
-265.73-1,322-1,619-5,704-266.05-83.07
Pretax Income
-12,395-11,427-87,803-27,348-19,60412,058
Income Tax Expense
-168.36-90.48-583.85-170.87--
Earnings From Continuing Operations
-12,227-11,337-87,219-27,177-19,60412,058
Net Income to Company
-12,227-11,337-87,219-27,177-19,60412,058
Net Income
-12,227-11,337-87,219-27,177-19,60412,058
Net Income to Common
-12,227-11,337-87,219-27,177-19,60412,058
Net Income Growth
-----637.48%
Shares Outstanding (Basic)
434140393940
Shares Outstanding (Diluted)
434140393943
Shares Change
6.77%4.09%0.66%-0.17%-8.46%9.88%
EPS (Basic)
-285.82-274.98-2202.00-690.62-497.32303.98
EPS (Diluted)
-285.82-274.98-2202.00-691.00-497.32280.00
EPS Growth
-----571.14%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-2,649111.3-31,858-4,895-12,045-10,341
Free Cash Flow Per Share
-61.922.70-804.31-124.40-305.57-240.13
Gross Margin
42.37%42.70%31.08%35.92%28.66%30.92%
Operating Margin
10.23%4.65%-61.15%-10.90%-5.18%-4.06%
Profit Margin
-14.37%-13.91%-139.12%-37.64%-25.86%19.97%
Free Cash Flow Margin
-3.11%0.14%-50.82%-6.78%-15.89%-17.13%
EBITDA
12,8538,101-33,999-3,877-890.45-135.45
EBITDA Margin
15.10%9.94%-54.23%-5.37%-1.18%-0.22%
D&A For EBITDA
4,1494,3094,3383,9913,0392,315
EBIT
8,7043,793-38,337-7,868-3,929-2,450
EBIT Margin
10.23%4.65%-61.15%-10.90%-5.18%-4.06%
Advertising Expenses
-107.5200.68159.382.3116.38